Motivational Interviewing, Part 2 - FAME Session

5 (2 votes)

  • Register
    • Non-Member - Free!
    • Regular Member - Free!
    • Retired - Free!
    • Early Career Physician - Free!
    • Resident - Free!
    • Student - Free!
    • Associate - Free!
    • ASAM Staff - Free!
    • International Member - Free!
    • Emeritus Member - Free!
    • Provisional Member - Free!
    • Fellow Member - Free!
    • Honorary Member - Free!
    • CRT Member - Free!

Motivational Interviewing, Part 2

This webinar will provide an overview of motivational interviewing (MI) and what makes MI different from other communication strategies. The webinar also covers the telehealth-related resources within the context of the COVID-19 pandemic.  

This session was recorded as part of the ASAM Fundamentals of Addiction Medicine ECHO (FAME) sessions. The participation in the live FAME sessions will provide CME but viewing this on-demand recording will not provide CME. To attend upcoming live FAME sessions (eligible for CME) please sign up on the website:

Learning Competencies

By completing this webinar, you will be able to:

  1.  Interact with patients and professional colleagues so as to display professionalism in all activities, by demonstrating commitment to the health and well-being of individuals and society through ethical practice, profession-led regulation, and high personal standards of behavior.
  2. Identify their feelings and attitudes that promote or prevent therapeutic responses to their patients with substance use disorders.
  3. Understand the addictive disorders as developmental biopsychosocial disorders.
  4. Take an evidence-based approach to detecting substance use disorders.
  5. Respond to positive substance use screening results with brief counseling strategies, appropriate to the patient’s readiness to change.
  6. Use motivational interviewing with patients ambivalent about changing their substance use behavior.
  7. Conduct a biopsychosocial and developmental ambulatory assessment of an adult with a suspected SUD to match the patient to an appropriate level of care.
  8. List the indications, contraindications and duration of treatment of evidence based pharmacotherapy for alcohol, tobacco, and opioid use disorders and refer patient to specialty care where appropriate.
  9. Reflect on the role of behavioral interventions for patients and families including formal intensive ambulatory and inpatient treatment and informal programs such as mutual aid groups in the recovery process for patients in their practice/ communities.  

Original Recording Information

Date: Friday, April 17, 2020

Time: 11:00 am - 1:00 pm (ET)


Angela Colistra, PhD 

Jennifer Hettema, PhD


On-Demand Session
Open to view video.
Open to view video. This webinar was recorded on April 17, 2020.